Revealing New Prospects: Antipsychotic Drugs Induces Anti-tumor Effects against Gastric Cancer through Inducing Apoptosis
Globally, Gastric Cancer (GC) ranks as the fifth leading cause of cancer-related deaths. GC is a multifaceted malignancy with diverse etiologies; however, understanding the shared molecular mechanisms can aid in discovering novel targeted therapies for GC. This study has employed a drug repositionin...
Saved in:
Published in | Current cancer drug targets Vol. 25; no. 5; p. 496 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
2025
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Globally, Gastric Cancer (GC) ranks as the fifth leading cause of cancer-related deaths. GC is a multifaceted malignancy with diverse etiologies; however, understanding the shared molecular mechanisms can aid in discovering novel targeted therapies for GC. This study has employed a drug repositioning approach to explore new drug candidates for treating GC.
The human GC cell lines AGS, MKN-45, and KATO-III were treated with different concentrations of dopamine, cabergoline, thioridazine, and entacapone to determine effective doses and IC50 values.
, cytotoxic activity on cancer cell lines was screened based on dose/time using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) was used to measure the mRNA expression of B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), and Proliferating Cell Nuclear Antigen (PCNA) in each group. The percentage of apoptotic cells was evaluated using Annexin V/PI staining.
Dopamine, cabergoline, thioridazine, and entacapone elicited cytotoxic effects on AGS and KATO-III cells in a dose-dependent manner and elevated the percentage of Annexin Vpositive cells, suggesting the occurrence of apoptosis. The expression of Bcl-2 and PCNA was significantly decreased, whereas the expression of Bax was considerably increased in the AGS and KATO-III cells compared to that in the blank group (p < 0.05); however, no similar effect was observed in MKN-45 cells.
Through
experiments, this study provides evidence that the antipsychotic drugs cabergoline, dopamine, thioridazine, and entacapone can inhibit gastric cancer growth in AGS and KATO-III cells. These findings suggest that these drugs could be repurposed as novel therapeutic agents for the treatment of gastric cancer. |
---|---|
AbstractList | Globally, Gastric Cancer (GC) ranks as the fifth leading cause of cancer-related deaths. GC is a multifaceted malignancy with diverse etiologies; however, understanding the shared molecular mechanisms can aid in discovering novel targeted therapies for GC. This study has employed a drug repositioning approach to explore new drug candidates for treating GC.
The human GC cell lines AGS, MKN-45, and KATO-III were treated with different concentrations of dopamine, cabergoline, thioridazine, and entacapone to determine effective doses and IC50 values.
, cytotoxic activity on cancer cell lines was screened based on dose/time using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) was used to measure the mRNA expression of B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), and Proliferating Cell Nuclear Antigen (PCNA) in each group. The percentage of apoptotic cells was evaluated using Annexin V/PI staining.
Dopamine, cabergoline, thioridazine, and entacapone elicited cytotoxic effects on AGS and KATO-III cells in a dose-dependent manner and elevated the percentage of Annexin Vpositive cells, suggesting the occurrence of apoptosis. The expression of Bcl-2 and PCNA was significantly decreased, whereas the expression of Bax was considerably increased in the AGS and KATO-III cells compared to that in the blank group (p < 0.05); however, no similar effect was observed in MKN-45 cells.
Through
experiments, this study provides evidence that the antipsychotic drugs cabergoline, dopamine, thioridazine, and entacapone can inhibit gastric cancer growth in AGS and KATO-III cells. These findings suggest that these drugs could be repurposed as novel therapeutic agents for the treatment of gastric cancer. |
Author | Ahangari, Ghasem Zaboli, Ehsan Janbabaei, Ghasem Lira, Sergio A Amjadi, Omolbanin Hedayatizadeh-Omran, Akbar |
Author_xml | – sequence: 1 givenname: Omolbanin orcidid: 0000-0002-1328-6285 surname: Amjadi fullname: Amjadi, Omolbanin organization: Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran – sequence: 2 givenname: Akbar orcidid: 0000-0002-9219-883X surname: Hedayatizadeh-Omran fullname: Hedayatizadeh-Omran, Akbar organization: Gastro-intestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran – sequence: 3 givenname: Ehsan orcidid: 0000-0003-4009-717X surname: Zaboli fullname: Zaboli, Ehsan organization: Department of Internal Medicine, Gastrointestinal Cancer Research Center, Non-Communicable Diseases, Mazandaran University of Medical Sciences, Sari, Iran – sequence: 4 givenname: Ghasem orcidid: 0000-0003-2651-6200 surname: Janbabaei fullname: Janbabaei, Ghasem organization: Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran – sequence: 5 givenname: Sergio A orcidid: 0000-0002-6742-3089 surname: Lira fullname: Lira, Sergio A organization: Immunology Institute, Ichan School of Medicine at Mount Sinai, New York, United States – sequence: 6 givenname: Ghasem orcidid: 0000-0003-1557-4050 surname: Ahangari fullname: Ahangari, Ghasem organization: Neuroimmunopsy-chooncogenetic Group, Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, P.O. Box: 1497716316, Tehran, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38984576$$D View this record in MEDLINE/PubMed |
BookMark | eNo1UMtKAzEUDaJorf6CZOF2NM9J4q7UWgtFRXRdbjPJdKDNDElG6d_bsbq4nAPnBfcSnYY2OIRuKbljVIl7QqksNSGm5IQLZZggJR2O8vIEjahWvJBSlefogmujxYGO0P7dfTnYNqHGL-4bv8U2dc7m9IAnITdd2ttNmxuLH2NfJ7wIVW9d-tWK3O_aiGfeD34MNTQhZTyHlOMhMIVgXcR5E9u-3hyTw8qka7vcpiZdoTMP2-Su_3CMPp9mH9PnYvk6X0wny2LNKcuFWkuqKmpECd6AVUIbqZWyTHqgnBrjNEjLDAijveAVV4ZUwDkFL4XWjI3RzbG369c7V6262Owg7lf_P2A_w5hfLg |
CitedBy_id | crossref_primary_10_1016_j_asjsur_2024_12_001 |
ContentType | Journal Article |
Copyright | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
Copyright_xml | – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.2174/0115680096303479240614061136 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
EISSN | 1873-5576 |
ExternalDocumentID | 38984576 |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Institute of Genetic Engineering and Biotechnology grantid: 772 – fundername: Mazandaran University of Medical Sciences, Iran grantid: MAZUMS.13746 |
GroupedDBID | CGR CUY CVF ECM EIF NPM |
ID | FETCH-LOGICAL-b312t-7b517d1946af9ac74895877c25fa13199e8a5c29a498f43d3790da331af548822 |
IngestDate | Wed May 07 07:47:13 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Dopamine drug repurposing gastric cancer apoptosis cabergoline entacapone thioridazine |
Language | English |
License | Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-b312t-7b517d1946af9ac74895877c25fa13199e8a5c29a498f43d3790da331af548822 |
ORCID | 0000-0003-2651-6200 0000-0002-6742-3089 0000-0003-4009-717X 0000-0003-1557-4050 0000-0002-9219-883X 0000-0002-1328-6285 |
PMID | 38984576 |
ParticipantIDs | pubmed_primary_38984576 |
PublicationCentury | 2000 |
PublicationDate | 2025-00-00 |
PublicationDateYYYYMMDD | 2025-01-01 |
PublicationDate_xml | – year: 2025 text: 2025-00-00 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Current cancer drug targets |
PublicationTitleAlternate | Curr Cancer Drug Targets |
PublicationYear | 2025 |
Score | 2.4164279 |
Snippet | Globally, Gastric Cancer (GC) ranks as the fifth leading cause of cancer-related deaths. GC is a multifaceted malignancy with diverse etiologies; however,... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 496 |
SubjectTerms | Antineoplastic Agents - pharmacology Antipsychotic Agents - pharmacology Apoptosis - drug effects Cell Line, Tumor Cell Proliferation - drug effects Drug Repositioning Humans Stomach Neoplasms - drug therapy Stomach Neoplasms - metabolism Stomach Neoplasms - pathology |
Title | Revealing New Prospects: Antipsychotic Drugs Induces Anti-tumor Effects against Gastric Cancer through Inducing Apoptosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38984576 |
Volume | 25 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3da5xAEMCXSwshL6Wl31_sQ97E9nRdXft2pNccgTShJBD6EmZ1zZlWPe68QvLX9U_r7IfGHG1o-6CIw56e83OdGWZ2CNnNxFjIOJY-Lxg6KKCED0ko_FjGPOdokgrQAf3Dz_HsNDo442ej0c9B1tK6le-y69_WlfyPVvEc6lVXyf6DZvsfxRN4jPrFPWoY93-l4y_qB9p52tnXaYrHy8bUTa5ssK8tXYVVmXkfl-uLlafbdOgELC3z23XVLL2pS-eACyjRUPT2QffxyLw9DcOy7-JjRpoAyqJZtM2qXA2N2m6Np8wOyvFins0w7w32SXUJuUkcOKqa7xLqsodypnK4wj90Dbma-0fV0oZkJ98k9InDXxFVW8c9nQ-yiA6gliBBGcn-HD_I1TCKEfJBFEPZmVckzOfcNoPppmZbE-0Q5IN5NrJtcDfnf-1fmZoG9EqF9s7wAx0lqbFa9BawW8NQHYvKsIFmm4jcxe-WbqzO3Ym2yBb6Kbrx6vHhNtl19_L-rjvZIdvd6A2fxtg2Jw_JA-eU0Ikl7BEZqfoxuerpokgX7en6QG-xRQ1b1LFFb9iiji3q2KKOLWrZoo4t2rFFe7aekNNP05O9me8adfiSBWHrJ5IHSR6kUQxFCple0IiLJMlCXkCAc3yqBPAsTAFf_SJiOUvScQ6MBVCgw4wm6lNyr25q9ZxQFWXA04iDCmVUiCgdyzCVLGGQCZYE8gV5Zp_U-cKuxnLePcOXf5S8Ijs3yL0m9wt8_dUbtCVb-dYo7BcpdnYS |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Revealing+New+Prospects%3A+Antipsychotic+Drugs+Induces+Anti-tumor+Effects+against+Gastric+Cancer+through+Inducing+Apoptosis&rft.jtitle=Current+cancer+drug+targets&rft.au=Amjadi%2C+Omolbanin&rft.au=Hedayatizadeh-Omran%2C+Akbar&rft.au=Zaboli%2C+Ehsan&rft.au=Janbabaei%2C+Ghasem&rft.date=2025-01-01&rft.eissn=1873-5576&rft.volume=25&rft.issue=5&rft.spage=496&rft_id=info:doi/10.2174%2F0115680096303479240614061136&rft_id=info%3Apmid%2F38984576&rft_id=info%3Apmid%2F38984576&rft.externalDocID=38984576 |